ACE2 and pulmonary arterial hypertension: The chronic inflammatory status implicated in the pathobiology of pulmonary vascular remodeling in PAH, as well as the reduced expression ACE2 (the transmembrane receptor of the SARS-CoV-2 virus) in PAH might contribute to decreased cytokine storm and reduced viral entrance in PAH.